Markets & Investing
Hong Kong falls to 36th place in global startup ecosystem rankings
Hong Kong falls to 36th place in global startup ecosystem rankings
But the city was noted for being a model of an open ang global ecosystem.
Hong Kong's economic crisis spills over to venture capital activity
VC investors have yet to see the end of their woes, even as domestic volatility has already dragged investment down.
HKEx chief Charles Li will not seek reappointment
His current contract will end in October 2021.
JD reportedly filing for second Hong Kong listing
The listing could occur on H2 2020.
Oriente bags $387.5m (US$50m) in series B funding round
Co-Chairman of Henderson Land and Wix.com named as new investors. Technology and data science company Oriente has secured approximately $387.5 (US...
SMC Electric delays proposed listing, share offer
Application monies will be refunded 16 March 2020.
Hang Seng Indexes launches two indices for Mainland stocks
They will track the performance of high-yield securities and tech firms.
Hong Kong unveils new advance funding arrangement for SMEs
This aims to encourage the private sector to conduct in-house R&D works.
IPOs in Hong Kong could raise $260b in 2020: report
Reforms on weighted voting right is boosting diversification of the capital market.
Hong Kong tipped to record 160 new listings in 2020
Alibaba’s HKEX debut may inspire US-listed Mainland firms to list in the city.
Investors' retirement savings withdrawal rate unsustainable: Schroders
The rate of 8.9% could deplete their savings in a decade.
Alibaba Group marks debut in Hong Kong Stock Exchange
The firm begins trading under stock code "9988".
Aligning the Interests of Fund Managers and Investors in Hong Kong
Actively managed investment funds are important. Amongst other benefits, the capital pooled and invested through such actively managed investment...
Alibaba prices Hong Kong retail investors' offer at up to $188 per share
Up to 575 million shares is up for grabs.
Biopharma firm SinoMab BioScience seeks $1.75b in IPO
It is focused on the treatment of immunological diseases, with a focus on mAb-based biologics.
Hedge fund assets hit all-time high at $722.33b despite unrest
China’s growing economy, highly-trained talent and robust regulatory landscape boosted the figure.
HKEX scraps $285.86b bid for London bourse
LSE’s board had unanimously rejected the proposal on 13 September.
Read Here
Advertise
Sign Up
